Difference between revisions of "Part:BBa K1813027"
 
(One intermediate revision by the same user not shown)
Line 2: Line 2:
 
<partinfo>BBa_K1813027 short</partinfo>
 
<partinfo>BBa_K1813027 short</partinfo>
  
−
A construct used to achieve the bacterial expression of CYP6CM1vQ (<html><b><a href="https://parts.igem.org/BBa_K1813003">BBa_K1813003</b></a></html>) under the regulative authority of the LacI repressor.
+
A construct used to achieve the bacterial expression of CYP6CM1vQ (<html><b><a href="https://parts.igem.org/Part:BBa_K1813003">BBa_K1813003</b></a></html>) under the regulative authority of the LacI repressor.
  
  
Line 10: Line 10:
 
<!-- -->
 
<!-- -->
 
<span class='h3bb'>Sequence and Features</span>
 
<span class='h3bb'>Sequence and Features</span>
−
<partinfo>BBa_K1813024 SequenceAndFeatures</partinfo>
+
<partinfo>BBa_K1813027 SequenceAndFeatures</partinfo>
  
  

Latest revision as of 08:44, 18 September 2015

CPY6CM1 Expression Cassette with LacI Reversed

A construct used to achieve the bacterial expression of CYP6CM1vQ (BBa_K1813003) under the regulative authority of the LacI repressor.


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 105
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Background

Repressed by the presence of the LacI regulatory element, this construct does not allow significant expression of CYP6CM1vQ without induction by the presence of Isopropyl β-D-1-thiogalactopyranoside in a bacterial host.